General Information
Revision date
2021-03-19
Product name
Metoprolol Succinate Extended Release Tablets USP 25mg,50 mg, 100 mg, 200 mg
1.2.1 Relevant identified uses
Antihypertensive; antianginal; antiarrhythmic (class II)
Manufacturer Name
Hetero Labs Limited
Icons in SDS
Company Information
company name
Camber Pharmaceuticals, Inc.
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H315, H360, H362, H412
Hazard statements
Code
Statements
H315
Causes skin irritation
H360
May damage fertility or the unborn child
H362
May cause harm to breast-fed children
H412
Harmful to aquatic life with long lasting effects
Section 2
Hazard statements
H315 Causes skin irritation. H360 May damage the unborn child. H362 May cause harm to breast-fed children. H412 Harmful to aquatic life with long lasting effects.
Precautionary statements
P201 Obtain special instructions before use. P260 Do not breathe dust or mist. P273 Avoid release to the environment. P280 Wear protective gloves. P302 + P352 IF ON SKIN: Wash with plenty of soap and water. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P501 Dispose of contents/ container to an approved incineration plant.
2.3 Other hazards
May cause eye irritation. May form explosible dust-air mixture if dispersed.